These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2. Israeli M; Finkel Y; Yahalom-Ronen Y; Paran N; Chitlaru T; Israeli O; Cohen-Gihon I; Aftalion M; Falach R; Rotem S; Elia U; Nemet I; Kliker L; Mandelboim M; Beth-Din A; Israely T; Cohen O; Stern-Ginossar N; Bercovich-Kinori A Nat Commun; 2022 Apr; 13(1):2237. PubMed ID: 35469023 [TBL] [Abstract][Full Text] [Related]
8. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice. Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A mBio; 2021 Apr; 12(2):. PubMed ID: 33879586 [TBL] [Abstract][Full Text] [Related]
9. Genome-wide CRISPR activation screen identifies candidate receptors for SARS-CoV-2 entry. Zhu S; Liu Y; Zhou Z; Zhang Z; Xiao X; Liu Z; Chen A; Dong X; Tian F; Chen S; Xu Y; Wang C; Li Q; Niu X; Pan Q; Du S; Xiao J; Wang J; Wei W Sci China Life Sci; 2022 Apr; 65(4):701-717. PubMed ID: 34431042 [TBL] [Abstract][Full Text] [Related]
10. Host proviral and antiviral factors for SARS-CoV-2. Lv L; Zhang L Virus Genes; 2021 Dec; 57(6):475-488. PubMed ID: 34510331 [TBL] [Abstract][Full Text] [Related]
11. Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells. Daniloski Z; Jordan TX; Wessels HH; Hoagland DA; Kasela S; Legut M; Maniatis S; Mimitou EP; Lu L; Geller E; Danziger O; Rosenberg BR; Phatnani H; Smibert P; Lappalainen T; tenOever BR; Sanjana NE Cell; 2021 Jan; 184(1):92-105.e16. PubMed ID: 33147445 [TBL] [Abstract][Full Text] [Related]
12. Whole genome CRISPR screening strategy to identify genes contributing to SARS-CoV-2 spike and VSV-G mediated entry. Hossain MS; Kerkvliet JG; Hoppe AD J Med Virol; 2023 Sep; 95(9):e29087. PubMed ID: 37707319 [TBL] [Abstract][Full Text] [Related]
13. Receptor utilization of angiotensin-converting enzyme 2 (ACE2) indicates a narrower host range of SARS-CoV-2 than that of SARS-CoV. Wang Q; Qiu Y; Li JY; Liao CH; Zhou ZJ; Ge XY Transbound Emerg Dis; 2021 May; 68(3):1046-1053. PubMed ID: 32794346 [TBL] [Abstract][Full Text] [Related]
14. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2. Islam ABMMK; Khan MA; Ahmed R; Hossain MS; Kabir SMT; Islam MS; Siddiki AMAMZ J Transl Med; 2021 Jan; 19(1):32. PubMed ID: 33413422 [TBL] [Abstract][Full Text] [Related]
16. Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2. Bittremieux W; Adams C; Laukens K; Dorrestein PC; Bandeira N J Proteome Res; 2021 Mar; 20(3):1464-1475. PubMed ID: 33605735 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Screening Using Reverse Transcriptase-Quantitative Polymerase Chain Reaction or CRISPR-Based Assays in Asymptomatic College Students. Rauch JN; Valois E; Ponce-Rojas JC; Aralis Z; Lach RS; Zappa F; Audouard M; Solley SC; Vaidya C; Costello M; Smith H; Javanbakht A; Malear B; Polito L; Comer S; Arn K; Kosik KS; Acosta-Alvear D; Wilson MZ; Fitzgibbons L; Arias C JAMA Netw Open; 2021 Feb; 4(2):e2037129. PubMed ID: 33570576 [TBL] [Abstract][Full Text] [Related]
18. Principles and Applications of CRISPR Toolkit in Virus Manipulation, Diagnosis, and Virus-Host Interactions. Jamehdor S; Pajouhanfar S; Saba S; Uzan G; Teimoori A; Naserian S Cells; 2022 Mar; 11(6):. PubMed ID: 35326449 [TBL] [Abstract][Full Text] [Related]
19. Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk. Chen P; Wang J; Xu X; Li Y; Zhu Y; Li X; Li M; Hao P Comput Biol Chem; 2022 Feb; 96():107613. PubMed ID: 34896769 [TBL] [Abstract][Full Text] [Related]